Share Prices & Company Research

Stockbroking

Abaco Capital Ord 0.001p

Current Price 1.47p Bid 1.45p Ask 1.55p Change 0.00%
Last Updated: 24/06/2018 13:51. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Abaco Capital plc (formerly Oxford Pharmascience Group plc, formerly Oxford Nutrascience plc) following completion of the Demerger of its former subsidiary Oxford Pharmascience Limited, the Company is now classified as an AIM Rule 15 Cash Shell and as such will be required to make an acquisition or acquisitions which constitutes a reverse takeover under Rule 14 of the AIM Rules (including seeking re-admission as an investing company, as defined under the AIM Rules) on or before the date falling six months from completion of the Demerger. In seeking and considering potential acquisitions, the Board of Directors intends to identify opportunities offering the potential to deliver value creation and returns to shareholders over the medium to long-term. The Company will consider investment opportunities in any sectors as they arise, however, the Board of Directors have a combined skill set and experience particular to the pharmaceutical, biotechnology and technology sectors.

Financial Highlights Year Ended 31/12/2017

Turnover
£0.00m
Operating Profit
£-0.62m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-11.54

Key Personnel

Christopher James Hill
Chief Financial Officer
David Robert Norwood
Non-Executive Chairman
John Geoffrey Goddard
Non-Executive Director

Stock Details

EPIC
ABA
ISIN
GB00B3LXPB43
Shares in Issue
1,205,661,619
Market cap
£18.09m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
1.45p
Ask Price
1.55p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
1.50p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
1.73p
52 Week Low
1.15p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Abaco Capital  Ord 0.001p Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
0.0
0.0
Inventory
0.0
0.0
Trade & Receivables
0.0
0.8
Cash & Receivables
19.2
16.9
Other Current Assets & Assets Held for Resale
0.0
5.0
Total Assets
19.3
22.7

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
0.3
0.2
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
0.3
0.2

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
19.0
22.6

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
0.0
1.2
Minority Interests
0.0
0.0
Retained Earnings
19.0
-11.7
Share Premium Account
0.0
31.8
Other Equity
0.0
1.3
Total Equity
19.0
22.6

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
-1.6
-1.3
Cashflow Before Financing
2.4
3.8
Increase / Decrease in Cash
2.4
3.8

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
0.0
0.8
Cost of Sales
0.0
0.6
Gross Profit
0.0
0.2
Operating Profit
-0.6
-2.0
Pre-Tax Profit
-0.5
-1.9
Profit / Loss for the Year
-2.1
-1.4
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.